GW’s Epidiolex Passes 3rd Phase 3 Trial
GW Pharma has cleared another hurdle in gaining FDA approval for its drug called Epidiolex, boosting stock value for the British drug maker.
Connecticut could become a staple for cannabis research as it is accepting research applications for hospitals, universities, growers, and dispensaries to study cannabis and cannabinoids.
An Illinois medical marijuana doctor is under investigation for providing almost half of the states 4400 medical marijuana patients with their cards.
A Massachusetts judge says a medical marijuana doctor was wrongly accused of improperly letting nurse practitioners prescribe marijuana although they already had the independent authority to do so.
Cannabis cultivation indoors could account for as much energy consumption as data centers in America.